VAERS Reports U012007

VAERS 2626609

MERCK & CO. INC. · HEP A (VAQTA) · Charge u012007

schwer

Staat: MO
Alter: 1,0
Geschlecht: M
Eingang: 04.05.2023
Impfdatum: 13.07.2022
Beginn: 13.07.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Eye movement disorder Febrile convulsion Pyrexia Seizure like phenomena Tremor Unresponsive to stimuli

Symptomtext

Father reports that after he had received his 1 year old vaccinations, he developed high fever and seizure-like activity several hours later consisting of eyes rolled back, shaking of bilateral upper and lower extremities, and being unresponsive. He was evaluated in the Emergency Department on 7/13/22 and thought to have had a febrile seizure. Father denied that he had rash, difficulty breathing, cough, congestion, vomiting, diarrhea, or other symptoms after receiving those vaccines.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Febrile convulsion
Hospital-Tage: -
Labordaten: No specific medical or laboratory tests were done after this event.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2431109

MERCK & CO. INC. · HEP A (VAQTA) · Charge U012007

moderat

Staat: GA
Alter: 4,0
Geschlecht: M
Eingang: 07.09.2022
Impfdatum: 08.08.2022
Beginn: 09.08.2022
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / RL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Alanine aminotransferase increased Aspartate aminotransferase increased Asthma Blood bilirubin increased Condition aggravated Decreased appetite Hepatic enzyme decreased Hepatitis viral test negative Lethargy Ocular icterus

Symptomtext

Moved on June 2022. On 8/8/22 rec'd quadracel and vaqta. 24 hours after vaccination developed scleral icterus, loss of appetite, and lethargy. Seen in office on 8/10/22. Found to have scleral icterus. Labs drawn and shown elevated AST, ALT, and bilirubin. Hepatitis panel and G6PD drawn and were negative/normal. By 8/11/22 was clinically doing better. Eating and playing usual amounts. No medications had been given. 8/12/22 was seen in office and clinically was normal. Labs showed decreasing liver enzymes. Was admitted for asthma exacerbation on 8/22/22 for 24 hours.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: 8/10/22 ALT: 2377 AST: 2221 tbili: 5.2 8/18/22 ALT: 1101 AST: 673 tbili: 2.3 awaiting labs 9/10/22
Aktuelle Erkrankungen: NONE
Vorgeschichte: ASTHMA
Andere Medikamente: NONE
Allergien: NONE
Vorherige Impfungen: -

VAERS 2419148

MERCK & CO. INC. · HEP A (VAQTA) · Charge U012007

mild

Staat: TN
Alter: 4,0
Geschlecht: M
Eingang: 24.08.2022
Impfdatum: 28.07.2022
Beginn: 29.07.2022
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / LL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site rash

Symptomtext

Thigh rash Bilat, steroid Treatment

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site rash
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Autistic d/o
Andere Medikamente: Montelukast 4mg Qhs, clonidin 0.1mg
Allergien: Barium sulfate
Vorherige Impfungen: -

VAERS 2284972

MERCK & CO. INC. · HEP A (VAQTA) · Charge U012007

mild

Staat: CA
Alter: 5,0
Geschlecht: F
Eingang: 19.05.2022
Impfdatum: 18.05.2022
Beginn: 18.05.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Lip discolouration Lip swelling Vomiting

Symptomtext

MOTHER CALLED OFFICE AT 2:00PM REPORTED PATIENT HAVING PURPLE LIP AND SWOLLEN LIP IN CAR AND DIZZYNESS . AFTER LEAVING OFFICE TOOK A NAP AT HOME AND WOKE UP VOMITTING . INSTURCTED PATIENT TO GO TO ER.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: PATIENT SEEN AT ER
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: NO
Allergien: NONE
Vorherige Impfungen: -

VAERS 2672289

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge U012007

gering

Staat: OH
Alter: 2,0
Geschlecht: F
Eingang: 16.08.2023
Impfdatum: 09.08.2022
Beginn: 15.08.2022
Tage bis Beginn: 6,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Immunisation reaction

Symptomtext

Adverse effect of other vaccines and biological substances, initial encounter on 2022-08-15, rash NOS on 2022-08-22.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Immunisation reaction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Encounter for routine child health examination NOS; Encounter for routine child health examination NOS; Need for immunization against single bacterial diseases
Vorgeschichte: -
Andere Medikamente: None
Allergien: -
Vorherige Impfungen: -

VAERS 2643551

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge U012007

gering

Staat: OH
Alter: 1,0
Geschlecht: M
Eingang: 09.06.2023
Impfdatum: 09.09.2022
Beginn: 14.09.2022
Tage bis Beginn: 5,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Immunisation reaction

Symptomtext

Adverse effect of other vaccines and biological substances, initial encounter on 2022-09-14.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Immunisation reaction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Encounter for routine child health examination NOS
Vorgeschichte: -
Andere Medikamente: None
Allergien: -
Vorherige Impfungen: -

VAERS 2643541

MERCK & CO. INC. · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge U012007

gering

Staat: OH
Alter: 1,9
Geschlecht: F
Eingang: 09.06.2023
Impfdatum: 09.08.2022
Beginn: 17.08.2022
Tage bis Beginn: 8,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Immunisation reaction

Symptomtext

Adverse effect of other vaccines and biological substances, initial encounter on 2022-08-17.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Immunisation reaction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Need for immunization against single bacterial diseases
Vorgeschichte: -
Andere Medikamente: None
Allergien: -
Vorherige Impfungen: -

VAERS 2586598

MERCK & CO. INC. · HEP A (VAQTA) · Charge U012007

gering

Staat: MI
Alter: -
Geschlecht: U
Eingang: 24.02.2023
Impfdatum: 20.02.2023
Beginn: 20.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No additional AE reported; Pediatric Patient was administered expired VAQTA; This spontaneous report was received from Pharmacist and refers to a pediatric patient (gender not reported). The patient's concurrent conditions, medical history or concomitant medications were not provided. On 20-FEB-2023, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection (lot #U012007 with expiration date: 18-JAN-2023) administered for prophylaxis (strength, dose and route of administration were not provided). No additional adverse events were reported. No Temperature Excursion reported prior to or at the time of this report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2581011

MERCK & CO. INC. · HEP A (VAQTA) · Charge u012007

gering

Staat: GA
Alter: -
Geschlecht: U
Eingang: 14.02.2023
Impfdatum: 09.02.2023
Beginn: 09.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No additional AEs were reported; Medical assistant reported that an expired VAQTA was given to patient; This spontaneous report has been received from a medical assistant concerning a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant therapies and drug/allergy history were not reported. On 09-FEB-2023, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA), 0.5 milliliter (ml), (lot # u012007, has been verified to be a valid lot number for hepatitis a vaccine, inactivated [VAQTA], expiration date reported and upon internal validation established as 18-JAN-2023) (anatomical location and route of administration were not reported) (Expired product administered). No additional adverse events were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2576029

MERCK & CO. INC. · HEP A (VAQTA) · Charge u012007

gering

Staat: TX
Alter: -
Geschlecht: U
Eingang: 06.02.2023
Impfdatum: 23.01.2023
Beginn: 23.01.2023
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No additional AEs were reported; Nurse reported that an expired VAQTA was given to a patient. No additional AEs were reported, No further information provided. No PQC.; This spontaneous report has been received from a nurse, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications, previous drug reactions, and allergies were not provided. On 23-JAN-2023, the patient was vaccinated with an expired dose of Hepatitis A Vaccine, Inactivated (VAQTA) intramuscular injection at a dose of 0.5 milliliter (ml) once as prophylaxis (lot number u012007 has been verified to be valid; expiration date reported and established as 18-JAN-2023) (expired product administered) (strength, route of administration, and anatomical location were not provided). No adverse effects were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2462619

MERCK & CO. INC. · HEP A (VAQTA) · Charge U012007

gering

Staat: IN
Alter: -
Geschlecht: U
Eingang: 28.09.2022
Impfdatum: 20.09.2022
Beginn: 20.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect dose administered No adverse event Product administered to patient of inappropriate age

Symptomtext

No other issues or concerns noted.; Medical assistant calling to report that a adult was given a pediatric dose vs the adult dose. Patient is almost 30 years of age. Admin on 9/20/2022 VAQTA: LOT: U012007 EXP: JAN 18, 2023 NO PQC No other issues or concerns noted.; Medical assistant calling to report that a adult was given a pediatric dose vs the adult dose. Patient is almost 30 years of age; This spontaneous report was received from a medical assistant and refers to an adult (almost 30 years old) patient of unknown gender. The patient's medical history, concurrent conditions concomitant therapies were not reported. On 20-SEP-2022, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) prefilled syringe, intramuscular injection, lot number U012007, expiration date: 18-JAN-2023, administered for prophylaxis (dose, strength, and route of administration were not provided). The patient was given pediatric dose instead of the adult one (product administered to patient of inappropriate age, incorrect dose administered). No other issues or concerns were noted (no adverse event).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2447775

MERCK & CO. INC. · HEP A (VAQTA) · Charge U012007

gering

Staat: MA
Alter: 14,0
Geschlecht: M
Eingang: 16.09.2022
Impfdatum: 16.09.2022
Beginn: 16.09.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Inappropriate schedule of product administration

Symptomtext

Parent here for well child visit, present with mother in exam room. Certified interpreter present via telephone. System reviewed prior to discussing vaccines with parent. No COVID vaccine noted in child's record. RN discussed vaccines due after reviewing records, including first dose of COVID vaccine, overdue 2nd dose of Hep A, and this year's dose of seasonal influenza vaccine. Mother verbalized her consent for child to receive vaccines. Agrees with this RN's understanding of vaccines child has received and not received thus far. After child received vaccines and before proceeding to waiting room for 15 minutes of observation post-vaccination, mother presented RN with COVID vaccination record card. Card indicates two previous doses of primary series Pfizer COVID vaccine. Pfizer EW0217 given 8/5/21, Pfizer EW0181 given 8/29/21. After visit was completed, RN located two separate records- by searching for different variations of patient's name- after vaccine administration, one record listing two previous doses of primary series Pfizer COVID vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: No known.
Vorgeschichte: None
Andere Medikamente: None
Allergien: No known food or medication allergy. Only allergy is to house dust
Vorherige Impfungen: -

VAERS 2439321

MERCK & CO. INC. · HEP A (VAQTA) · Charge U012007

gering

Staat: OH
Alter: 1,0
Geschlecht: U
Eingang: 10.09.2022
Impfdatum: 12.07.2022
Beginn: 26.07.2022
Tage bis Beginn: 14,0
Dosis: 2
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Extra dose administered No adverse event

Symptomtext

No additional AE; 1 year old patient that received VAQTA, MMR-II, and VARIVAX on 12-JUL-2022 and received the VAQTA, MMR-II, and VARIVAX again on 26-JUL-2022.; This spontaneous report has been received from a nurse practitioner referring to a 1 year-old-patient of unknown gender. The patient's pertinent medical history, previous drug reactions or allergies, and concomitant medications were not reported. On 12-JUL-2022, the patient was vaccinated with the first dose of hepatitis a vaccine, inactivated (VAQTA) 0.5 mL intramuscularly, hepatitis a vaccine, inactivated varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 mL subcutaneously, and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) 0.5 mL; all vaccines for prophylaxis(strengths, lot numbers, anatomical locations, routes of administration, and expirations dates were not provided). On 26-JUL-2022, the patient received the second dose with hepatitis a vaccine, inactivated (VAQTA), 0.5 mL (lot number U012007 has been verified to be a valid lot number, expiration date not reported, but upon internal validation established as 18-JAN-2023), hepatitis a vaccine, inactivated varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 mL (lot number T036561 has been verified to be a valid lot number, expiration date not reported, but upon internal validation established as 28-OCT-2022) and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) 0.5 mL (lot number T033814 has been verified to be a valid lot number, expiration date not reported, but upon internal validation established as 05-OCT-2022); all vaccines for prophylaxis (strengths, anatomical locations, and routes of administration were not provided) (inappropriate schedule of vaccine administered). No adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2403726

MERCK & CO. INC. · HEP A (VAQTA) · Charge U012007

gering

Staat: IL
Alter: -
Geschlecht: U
Eingang: 06.08.2022
Impfdatum: 15.07.2022
Beginn: 15.07.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Wrong product administered

Symptomtext

No additional AE reported; Caller reports that a patient was scheduled to receive a dose of RECOMBIVAX HB but was inadvertently administered a dose of VAQTA instead on 15-JUL-2022; This spontaneous report has been received from a registered nurse concerning to a patient of unknown age and gender. The patient's concurrent conditions, medical history, drug/allergy reactions, and concomitant therapies, were not reported. The nurse stated that on 15-JUL-2022, the patient was scheduled to receive a dose of hepatitis B vaccine (recombinant) (RECOMBIVAX HB) (strength, dose/route/frequency of administration, lot number, and expiration date not reported) for prophylaxis but was inadvertently administered a dose of hepatitis A vaccine, inactivated (VAQTA) (wrong product administered) at a dose of 0.5 mL (strength, route/frequency of administration not reported) (lot number U012007 with expiration date on 18-JAN-2023) for prophylaxis. The nurse denied that this was related to a product confusion and stated that the nurse simply grabbed the wrong vaccine to administer. No additional adverse events (AE) were reported (not adverse event).

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2362638

MERCK & CO. INC. · HEP A (VAQTA) · Charge U012007

gering

Staat: IL
Alter: 1,0
Geschlecht: M
Eingang: 08.07.2022
Impfdatum: 05.07.2022
Beginn: 05.07.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Wrong product administered

Symptomtext

Patient received incorrect vaccine. No current reportable side effects.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: NKA
Vorherige Impfungen: -

VAERS 2314555

MERCK & CO. INC. · HEP A (VAQTA) · Charge u012007

gering

Staat: MI
Alter: 1,0
Geschlecht: F
Eingang: 09.06.2022
Impfdatum: 24.05.2022
Beginn: 24.05.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Blister Erythema

Symptomtext

Redness and blister all over body after vaccines administered after getting home from clinic. Physician determined reaction was from varicella vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Blister
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2270763

MERCK & CO. INC. · HEP A (VAQTA) · Charge U012007

gering

Staat: VA
Alter: 2,0
Geschlecht: M
Eingang: 11.05.2022
Impfdatum: 10.05.2022
Beginn: 10.05.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Inappropriate schedule of product administration

Symptomtext

Pentacel was given too early. Patient needed a plain Polio and a plain Haemophilus Influenzae.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: nkda
Vorherige Impfungen: -

VAERS 2259589

MERCK & CO. INC. · HEP A (VAQTA) · Charge U012007

gering

Staat: SD
Alter: 1,3
Geschlecht: U
Eingang: 30.04.2022
Impfdatum: 14.03.2022
Beginn: 11.04.2022
Tage bis Beginn: 28,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Inappropriate schedule of product administration No adverse event

Symptomtext

Patient had no symptoms or adverse effects from administration of vaccine.; patient received two doses of VAQTA at less than minimum interval; This spontaneous report was received from a nurse and refers to a 15-month-old patient of unknown gender. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On 14-MAR-2022, the patient was vaccinated with a dose of hepatitis a vaccine, inactivated (VAQTA) first dose (strength, dose, lot #, expiration date, and route of administration were not provided) for prophylaxis. On 11-APR-2022, the patient was vaccinated with a dose of hepatitis a vaccine, inactivated (VAQTA) second dose, 0.5 milliliter, lot #U012007, expiration date: 18-JAN-2023 (strength, and route of administration were not provided) for prophylaxis (Inappropriate schedule of product administration). No adverse events were reported (No adverse event).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2250194

MERCK & CO. INC. · HEP A (VAQTA) · Charge U012007

gering

Staat: SD
Alter: 1,3
Geschlecht: F
Eingang: 25.04.2022
Impfdatum: 11.04.2022
Beginn: 11.04.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Inappropriate schedule of product administration

Symptomtext

Hep A was given after checking the system for other shots. None were listed. The father responded no to the question whether child had received shots within the previous 4 weeks. The next day another system was checked and found that a Hep A was given on 3/14/22 falling outside the 6 month allowance. The father was contacted and reported that the child's mother may have taken her to the 3/14/22 appointment. The additional shots given on 4/11/22 are within the 4 week time period except Varicella which falls under exception considering 4 week interval valid.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -